Evidence map›Paper›PMID 21412435›Full record

ArticlePloS one2011

Gene-trap mutagenesis identifies mammalian genes contributing to intoxication by Clostridium perfringens ε-toxin.

Susan E Ivie, Christine M Fennessey, Jinsong Sheng, Donald H Rubin, Mark S McClain

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 72 citations in OpenAlex.

  1. Effect ofNAM journal · 2025
    Article
  2. Epsilon Toxin fromToxins · 2024
    Article
  3. Article
  4. Review
  5. Toxins · 2023
    Article
  6. Interaction ofToxins · 2022
    Article
  7. Article
  8. Toxins · 2020
    Article
  9. Article
  10. Article
  11. Article
  12. NPJ vaccines · 2019
    Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Susan E IvieDivision of Infectious Disease, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
Christine M Fennessey
Jinsong Sheng
Donald H Rubin
Mark S McClain
Vanderbilt University · USVA Tennessee Valley Healthcare System · US

Funding

Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
Inhibition of Clostridium perfringens epsilon toxinR01AI079123 · NIAID · VANDERBILT UNIVERSITY · PI MCCLAIN, MARK S · 2008 to 2011
$1.5M
Inhibitors to Clostridium perfrigens epsilon toxinR21AI065435 · NIAID · VANDERBILT UNIVERSITY · PI MCCLAIN, MARK S · 2006 to 2007
$327k
NIAID NIH HHS R01 AI079123NIAID NIH HHS R01-AI079123NIAID NIH HHS R21 AI065435NIAID NIH HHS R21-AI065435NIDDK NIH HHS P30 DK058404NIDDK NIH HHS P30-DK058404
6 · The paper itself

Abstract

The Clostridium perfringens ε-toxin is an extremely potent toxin associated with lethal toxemias in domesticated ruminants and may be toxic to humans. Intoxication results in fluid accumulation in various tissues, most notably in the brain and kidneys. Previous studies suggest that the toxin is a pore-forming toxin, leading to dysregulated ion homeostasis and ultimately cell death. However, mammalian host factors that likely contribute to ε-toxin-induced cytotoxicity are poorly understood. A library of insertional mutant Madin Darby canine kidney (MDCK) cells, which are highly susceptible to the lethal affects of ε-toxin, was used to select clones of cells resistant to ε-toxin-induced cytotoxicity. The genes mutated in 9 surviving resistant cell clones were identified. We focused additional experiments on one of the identified genes as a means of validating the experimental approach. Gene expression microarray analysis revealed that one of the identified genes, hepatitis A virus cellular receptor 1 (HAVCR1, KIM-1, TIM1), is more abundantly expressed in human kidney cell lines than it is expressed in human cells known to be resistant to ε-toxin. One human kidney cell line, ACHN, was found to be sensitive to the toxin and expresses a larger isoform of the HAVCR1 protein than the HAVCR1 protein expressed by other, toxin-resistant human kidney cell lines. RNA interference studies in MDCK and in ACHN cells confirmed that HAVCR1 contributes to ε-toxin-induced cytotoxicity. Additionally, ε-toxin was shown to bind to HAVCR1 in vitro. The results of this study indicate that HAVCR1 and the other genes identified through the use of gene-trap mutagenesis and RNA interference strategies represent important targets for investigation of the process by which ε-toxin induces cell death and new targets for potential therapeutic intervention.

Indexed as

Alternative SplicingAnimalsBacterial ToxinsCell DeathCell LineDogsGene Knockdown TechniquesGenesHumansMammalsMembrane ProteinsMutagenesis, InsertionalProtein BindingRNA, Small InterferingSequence AlignmentTransfectionBacterial ToxinsClostridium perfringens epsilon-toxinMembrane ProteinsRNA, Small Interfering

Identifiers

PMID21412435
PMCPMC3055893
OpenAlexW2095024221

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.